---
document_datetime: 2026-01-13 14:07:16
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/winlevi-epar-all-authorised-presentations_en.pdf
document_name: winlevi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8281402
conversion_datetime: 2026-01-14 07:20:16.016901
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.68.0
  docling-core: 2.59.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/25/1927/001 | Winlevi           | 10 mg/g    | Cream                 | Cutaneous use             | tube (alu)            | 10 g                      | 1 tube      |
| EU/1/25/1927/002 | Winlevi           | 10 mg/g    | Cream                 | Cutaneous use             | tube (alu)            | 30 g                      | 1 tube      |
| EU/1/25/1927/003 | Winlevi           | 10 mg/g    | Cream                 | Cutaneous use             | tube (alu)            | 60 g                      | 1 tube      |